Zimmer Biomet (ZBH) PT Raised to $172 at Baird
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mailGet Alerts ZBH Hot Sheet
Price: $98.81 +4.16%
Rating Summary:
18 Buy, 27 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 11 | New: 48
Rating Summary:
18 Buy, 27 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 11 | New: 48
Join SI Premium – FREE
Baird analyst Jeffrey Johnson raised the price target on Zimmer Biomet (NYSE: ZBH) to $172.00 (from $145.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Morgan Stanley Downgrades BE Semiconductor (BESI:NA) (BESIY) to Equalweight
- Spotify (SPOT) PT Raised to $625 at Raymond James
- Tractor Supply Company (TSCO) PT Raised to $34 at Truist Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
